Federal Register - August 9, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices The previously approved collections of information are subject to review by OMB under the PRA. The collections of information in 21 CFR part 314 for NDAs and in 21 CFR parts 314 and 601
for annual reports, ANDAs, and supplements to applications have been approved under OMB control numbers 09100001 and 09100338, respectively.
The collections of information in 21
CFR part 211 for current good manufacturing practices for finished pharmaceuticals and medical gases have been approved under OMB control number 09100139.
III. Electronic Access Persons with access to the internet may obtain the guidance at either https www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs or https
www.regulations.gov.
Contact Person: Najma S. Begum, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 6707 Democracy Boulevard, Bethesda, MD 208925452, 301 5948894, begumn@niddk.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS
Dated: August 4, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116901 Filed 8621; 8:45 am BILLING CODE 414001P
Dated: August 2, 2021.
Lauren K. Roth, Acting Principal Associate Commissioner for Policy.
FR Doc. 202116930 Filed 8621; 8:45 am
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute on Aging; Notice of Closed Meeting
BILLING CODE 416401P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR19319: NIDDK
Central Repositories Non-Renewable Sample Access X01 Review.
Date: September 13, 2021.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 Telephone Conference Call.
VerDate Sep<11>2014
17:26 Aug 06, 2021
Jkt 253001
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis Panel; T32/T35
Review January 2022 Council.
Date: October 20, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 Video Meeting.
Contact Person: Anita H. Undale, MD, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building, Suite 2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301827
7428, anita.undale@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
43557
Dated: August 4, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116951 Filed 8621; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases;
Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council, September 09, 2021, 10:00 a.m.
to September 10, 2021, 12:45 p.m., National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 which was published in the Federal Register on June 02, 2021, FR Doc 202111516, 86 FR 29592.
The meeting notice is amended to change the meeting time from September 910, 2021, 10:00 a.m. to 1:45 p.m. To September 910, 2021, 10:00 a.m. to 12:45 p.m. The meeting is partially Closed to the public.
Dated: August 4, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116952 Filed 8621; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special
E:FRFM09AUN1.SGM
09AUN1
